How is Glycogen Supercompensation Regulated in Human Skeletal Muscle
Launched by UNIVERSITY OF COPENHAGEN · Mar 1, 2018
Trial Information
Current as of July 06, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • male
- • BMI between BMI 20-25 kg/m2
- • healthy and not using medication
- • not smoking
- • habitual physical activity level of 2 - 6 hours pr. week
- • no incidence of diabetes, cardiovascular disease or other metabolic diseases in close family
- Exclusion Criteria:
- • female
- • BMI below 20 and above 25 kg/m2
- • using medication
- • smoking
- • habitual physical activity level below 2 h pr. week or above 6 hours pr. week
- • incidence of diabetes, cardiovascular disease or metabolic disease in close family
About University Of Copenhagen
The University of Copenhagen, a leading research institution in Denmark, is dedicated to advancing medical knowledge and improving patient outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including health sciences, pharmacology, and biotechnology, to design and conduct rigorous clinical studies. Committed to ethical standards and scientific integrity, the University of Copenhagen aims to contribute significantly to the global medical community by facilitating groundbreaking research that addresses pressing healthcare challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, Capital Region, Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials